Caprock »

Atai Life Sciences Nv shares owned by Caprock

Quarter-by-quarter ownership of Atai Life Sciences Nv shares owned by Caprock from 13F filings

Historical chart of Caprock investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by Caprock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by Caprock

Quarter filed Position value Share count Share price at filing
2025-12-31 $213k 52k 4.09

More positions owned by Caprock

Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Sentinelone Cl A (S)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Meta Platforms Cl A (META)
Liquidia Corporation Com New (LQDA)
Equity Lifestyle Properties (ELS)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)

View all positions for Caprock

Top funds holding Atai Life Sciences Nv

Adage Capital Partners GP
Citadel Advisors
Ally Bridge Group
ARK Investment Management
T. Rowe Price Investment Management
Eagle Health Investments
Susquehanna International
Millennium Management
Goldman Sachs Group
Moore Capital Management
ADAR1 Capital Management
Jpmorgan Chase & Co
Jane Street
Brown University
D. E. Shaw & Co

View all funds holding Atai Life Sciences Nv